Trials / Active Not Recruiting
Active Not RecruitingNCT07119242
Evaluate the Diagnostic Efficacy, Pharmacokinetics and Safety of 68Ga-DOTATATE Injection PET/CT in NETs
- Status
- Active Not Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 95 (estimated)
- Sponsor
- HTA Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Evaluate the diagnostic efficacy, pharmacokinetics and safety of 68Ga-DOTATATE injection PET/CT in NETs
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 68Ga-DOTATATE Injection | The eligible subjects who participate in 68Ga study will be intravenously injected with 68Ga-DOTATATE Injection on Day1，and undergo PET/CT examination within 60 minutes after injection. Corresponding safety examination is performed before administration of 68Ga-DOTATATE Injection, 3h±1.0h after administration, and Day2. Telephone safety visit is conducted at Day7 after administration. |
Timeline
- Start date
- 2024-01-08
- Primary completion
- 2024-11-11
- Completion
- 2025-12-31
- First posted
- 2025-08-13
- Last updated
- 2025-08-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07119242. Inclusion in this directory is not an endorsement.